Skin News and Research

RSS

Researchers pinpoint new mechanism that potently activates T-cells in leprosy

UCLA researchers pinpointed a new mechanism that potently activates T-cells, the group of white blood cells that play a major role in fighting infections.

26 Mar 2012

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

For the first time NHS patients in Wales with peripheral nerve pain (known as peripheral neuropathic pain) can be treated with a patch containing capsaicin, which can provide at least 12 weeks pain relief following a single 30- or 60-minute application.

25 Mar 2012

Obesity in later life linked to decreased mental faculties

The study found said out of 250 test subjects involving people over 59 years old, people between 60 and 70 who had the highest BMIs also had the lowest cognitive function. There was also a connection between visceral fat -- otherwise known as the belly fat around the torso - and poor mental abilities. The study, which was published in the British journal Age and Aging, measured the subjects fat-related measures including BMI, waist circumference and the amount of visceral - which could be close to organs - and subcutaneous -under the skin - fat using a abdominal CT scan. Cognitive ability was determined by a test called a Mini-Mental State Examination.

25 Mar 2012

Allergy season comes early with high pollen counts

After the end of an unusually warm winter the spring has come early and this has affected asthmatics in parts of the South and Midwest this year. The 25 to 35 percent of people who suffer from hay fever, the early arrival of warm weather meant an unusually early start to allergy season due to the abundance of pollens.

25 Mar 2012

Relief for dry eyes through scleral contact lenses

Susan Loughman is among the tens of millions of Americans who suffer dry eyes. She has an especially bad condition, which makes it feel like there's sandpaper in her eyes.

23 Mar 2012

Max Planck researchers obtain somatic stem cells from fully differentiated somatic cells

Breaking new ground, scientists at the Max Planck Institute for Molecular Biomedicine in M-nster, Germany, have succeeded in obtaining somatic stem cells from fully differentiated somatic cells. Stem cell researcher Hans Sch-ler and his team took skin cells from mice and, using a unique combination of growth factors while ensuring appropriate culturing conditions, have managed to induce the cells' differentiation into neuronal somatic stem cells.

23 Mar 2012

OncoSec to present data from head and neck cancer studies at two upcoming conferences

OncoSec Medical Incorporated., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company has been selected to present data from its Phase III and IV head and neck cancer studies at two upcoming conferences.

23 Mar 2012

Cardiff team receives European grants to develop 'RealTCut' surgical simulation

Highly realistic surgical simulation which reduces patient risk has become the 100th Cardiff University project to win an award under the European Union's prime research funding scheme, the Seventh Framework Programme.

23 Mar 2012

Scientists artificially derive brain stem cells from connective tissue of mice

These stem cells can reproduce and be converted into various types of brain cells. To date, only reprogramming in brain cells that were already fully developed or which had only a limited ability to divide was possible. The new reprogramming method presented by the Bonn scientists and submitted for publication in July 2011 now enables derivation of brain stem cells that are still immature and able to undergo practically unlimited division to be extracted from conventional body cells.

23 Mar 2012

Memorial Sloan-Kettering first in N.Y. to offer radioactive seed localization for breast cancer

Memorial Sloan-Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove very small breast cancers that can be seen on a mammogram but not felt in the breast.

22 Mar 2012

Researchers explain how obscurins suppress breast cancer formation

A new discovery published online in The FASEB Journal may lead to a new tool to help physicians assess breast cancer risk as well as diagnose the disease. In the report, researchers from Johns Hopkins University and the University of Maryland, explain how proteins, called "obscurins," once believed to only be in muscle cells, act as "tumor suppressor genes" in the breast.

22 Mar 2012

Two Brandeis researchers receive Canada Gairdner Award

Two distinguished Brandeis researchers, whose long-standing collaboration led to pioneering discoveries about the workings of the biological clock and its role in circadian rhythms, today were awarded the prestigious Canada Gairdner Award, that nation's foremost international scientific honor.

22 Mar 2012

Simple and accurate test for peanut allergy

The Murdoch Children’s Research Institute and University of Melbourne researchers discovered a two-pronged blood test will confirm peanut allergies instead of putting children through risky oral food challenge tests.

21 Mar 2012

New way to accurately test for peanut allergy

Researchers from Murdoch Childrens Research Institute and the University of Melbourne have identified a new way to accurately test for peanut allergy.

21 Mar 2012

Issues and treatments of chronic skin wounds

The skin is the body's largest organ and an indispensable part of the immune system. As the body's outermost line of defense against microbes, the skin provides important protection against potentially toxic environmental elements. One subset of immune cells, thymus-derived T-cells play an important role in the skin's response to injury, particularly with respect to wound healing.

21 Mar 2012

ISCO fourth quarter revenue increases 110% to $1.1 million

International Stem Cell Corporation today announced year-end financial results for the year ended December 31, 2011.

21 Mar 2012

EJSO publishes results from Cytori breast reconstruction cell therapy trial

Cytori Therapeutics announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.

20 Mar 2012

FDA, Agilent partner to develop new tools for detection of salmonella subtypes

Agilent Technologies Inc. today announced that it has entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration to develop new tools to detect and analyze pathogens in food.

20 Mar 2012

Mayo Clinic researchers train mouse immune systems to eradicate skin cancer from within

Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, uses a genetically engineered version of the vesicular stomatitis virus to deliver a broad spectrum of genes derived from melanoma cancer cells directly into tumors.

20 Mar 2012

New information on efficacy of CLA in treating Crohn's disease

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) research team at Virginia Tech has discovered important new information on the efficacy of conjugated linoleic acid (CLA) in treating Crohn's disease, a form of inflammatory bowel disease (IBD). CLA is a naturally occurring acid found in meat and dairy products known for its anti-cancer and immune modulatory properties.

20 Mar 2012